Your browser doesn't support javascript.
loading
Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies.
Wagner, Nikolaus B; Weide, Benjamin; Gries, Mirko; Reith, Maike; Tarnanidis, Kathrin; Schuermans, Valerie; Kemper, Charlotte; Kehrel, Coretta; Funder, Anne; Lichtenberger, Ramtin; Sucker, Antje; Herpel, Esther; Holland-Letz, Tim; Schadendorf, Dirk; Garbe, Claus; Umansky, Viktor; Utikal, Jochen; Gebhardt, Christoffer.
Afiliação
  • Wagner NB; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany. nikolausbenjamin.wagner@kssg.ch.
  • Weide B; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany. nikolausbenjamin.wagner@kssg.ch.
  • Gries M; Department of Dermatology, University Hospital Tuebingen, Tuebingen, Germany. nikolausbenjamin.wagner@kssg.ch.
  • Reith M; Department of Dermatology, Venereology and Allergology, Cantonal Hospital St. Gallen, Rorschacher Strasse 95, 9007, St. Gallen, Switzerland. nikolausbenjamin.wagner@kssg.ch.
  • Tarnanidis K; Department of Dermatology, University Hospital Tuebingen, Tuebingen, Germany.
  • Schuermans V; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Kemper C; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany.
  • Kehrel C; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Funder A; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany.
  • Lichtenberger R; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Sucker A; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany.
  • Herpel E; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Holland-Letz T; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany.
  • Schadendorf D; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Garbe C; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany.
  • Umansky V; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Utikal J; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany.
  • Gebhardt C; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.
J Immunother Cancer ; 7(1): 343, 2019 12 05.
Article em En | MEDLINE | ID: mdl-31806053
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Calgranulina A / Calgranulina B / Microambiente Tumoral / Receptor de Morte Celular Programada 1 / Antineoplásicos Imunológicos / Melanoma Tipo de estudo: Prognostic_studies Idioma: En Revista: J Immunother Cancer Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Calgranulina A / Calgranulina B / Microambiente Tumoral / Receptor de Morte Celular Programada 1 / Antineoplásicos Imunológicos / Melanoma Tipo de estudo: Prognostic_studies Idioma: En Revista: J Immunother Cancer Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha